Computational drug design

PDB entry 1q0b (KSP1 inhibition) visualized with LigandScout

Our research interest is to develop and improve molecular modeling methods, while learning from experimental biology and chemistry. Although traditional structure- and ligand-based modeling will always stay a part of our work, we are currently engaging in prediction of multi-target activities, off-target effects and toxicity.

A few key papers:

[More in "Science and Publications" ...]